TH98294B - Composition and methods for adjusting C-kit receptors - Google Patents
Composition and methods for adjusting C-kit receptorsInfo
- Publication number
- TH98294B TH98294B TH701005283A TH0701005283A TH98294B TH 98294 B TH98294 B TH 98294B TH 701005283 A TH701005283 A TH 701005283A TH 0701005283 A TH0701005283 A TH 0701005283A TH 98294 B TH98294 B TH 98294B
- Authority
- TH
- Thailand
- Prior art keywords
- raf
- remedial
- abl
- adjusting
- composition
- Prior art date
Links
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 title abstract 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- -1 PDGRB Proteins 0.000 abstract 2
- 230000002159 abnormal effect Effects 0.000 abstract 2
- 230000000246 remedial effect Effects 0.000 abstract 2
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 abstract 1
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 abstract 1
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 abstract 1
- 101100127166 Escherichia coli (strain K12) kefB gene Proteins 0.000 abstract 1
- 101150036586 FES gene Proteins 0.000 abstract 1
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 abstract 1
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 abstract 1
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 abstract 1
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 abstract 1
- 101100457333 Homo sapiens MAPK11 gene Proteins 0.000 abstract 1
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 abstract 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 abstract 1
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 abstract 1
- 101000606502 Homo sapiens Protein-tyrosine kinase 6 Proteins 0.000 abstract 1
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 abstract 1
- 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 abstract 1
- 101000922131 Homo sapiens Tyrosine-protein kinase CSK Proteins 0.000 abstract 1
- 101150028321 Lck gene Proteins 0.000 abstract 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 abstract 1
- 102100026929 Mitogen-activated protein kinase 11 Human genes 0.000 abstract 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 abstract 1
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 abstract 1
- 101150038994 PDGFRA gene Proteins 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 102100039810 Protein-tyrosine kinase 6 Human genes 0.000 abstract 1
- 108010029869 Proto-Oncogene Proteins c-raf Proteins 0.000 abstract 1
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 abstract 1
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 abstract 1
- 102000001332 SRC Human genes 0.000 abstract 1
- 108060006706 SRC Proteins 0.000 abstract 1
- 101001045447 Synechocystis sp. (strain PCC 6803 / Kazusa) Sensor histidine kinase Hik2 Proteins 0.000 abstract 1
- 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 abstract 1
- 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 abstract 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 abstract 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 abstract 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 abstract 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 abstract 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 abstract 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 239000003909 protein kinase inhibitor Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Abstract
การประดิษฐ์ จะให้สารประกอบ และ องค์ประกอบในทางเภสัชกรรมของมัน, ซึ่ง มีประโยชน์เป็นสารยับยั้งโปรตีน ไคเนส, รวมทั้งวิธีการสำหรับการใช้สารประกอบดังกล่าวในการ รักษา, การเยียวยา หรือ การป้องกันสภาวะที่สัมพันธุ์กับไคเนส แอคตีวิตี้ที่ผิดปกติ หรือ ไม่ถูกกำกับ ควบคุม ในบางรูปแบบ, การประดิษฐ์จะให้วิธีการสำหรับการใช้สารประกอบดังกล่าวเพื่อการรักษา, การเยียวยา หรือ การป้องกันโรค หรือ ความผิดปกติที่มีส่วนเกี่ยวข้องกับการแอคติเวชั่นที่ผิดปกติ ของ c-kit, PDGFRa, PDGRB, CSF1R, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGFB, SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2B, BRK, KDR, c-raf หรือ b-raf ไคเนส, หรือ รูปฟอร์ม มิวแตนท์ของมัน The invention provides compounds and their pharmaceutical constituents, which are useful as protein kinase inhibitors, as well as a means for their use in the treatment, remedial or prevention of conditions associated with chi. Nest Abnormal or unregulated activity, in some ways, the invention provides a means for the use of the compound for therapeutic, remedial, or prophylactic purposes or associated with Abnormal activity of c-kit, PDGFRa, PDGRB, CSF1R, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGFB, SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck. , Syk, RAF, MKK4, MKK6, SAPK2B, BRK, KDR, c-raf or b-raf kinase, or its mutant form.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH98294A TH98294A (en) | 2009-09-17 |
| TH98294B true TH98294B (en) | 2009-09-17 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR063343A1 (en) | COMPOUNDS FOR MODULAR C-KIT AND PDGFR RECEIVERS | |
| ECSP10010044A (en) | COMPOUNDS OF 5- (4- (HALO-ALCOXI) -PENYL) -PIRIMIDIN-2-AMINA AND COMPOSITIONS AS KINASE INHIBITORS | |
| ATE520682T1 (en) | 2-HETEROARYLAMINOPYRIMIDENE DERIVATIVES AS KINASE INHIBITORS | |
| Ghosh et al. | Covalent inhibition in drug discovery | |
| Blay et al. | Nilotinib: a novel, selective tyrosine kinase inhibitor | |
| EA200901654A1 (en) | INHIBITORS AND METHODS WITH THEIR USE | |
| Okada et al. | Memantine protects thalamocortical hyper‐glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc− | |
| WO2007022268A3 (en) | Compounds and compositions as protein kinase inhibitors | |
| EA201000003A1 (en) | PROTEINKINAZ INHIBITORS AND METHODS OF THEIR APPLICATION | |
| Wang et al. | Conformation-specific effects of Raf kinase inhibitors: miniperspective | |
| WO2005034869A3 (en) | Compounds and compositions as protein kinase inhibitors | |
| DE602006009968D1 (en) | N4-PHENYL-CHINAZOLIN-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE ERBB-TYPE-I RECEPTORTOSROSINE KINASE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | |
| CO6270257A2 (en) | DERIVATIVES OF PIRIDAZINONA | |
| TN2009000070A1 (en) | Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors | |
| TW200800989A (en) | Pyrrolopyridine kinase inhibiting compounds | |
| EA201001238A1 (en) | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS | |
| ATE469151T1 (en) | PYRROLOPYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | |
| UA95244C2 (en) | Compounds and methods for kinase modulation, and indications therefor | |
| NO20074722L (en) | Use of an epidermal growth factor receptor kinase inhibitor (EGRR) in gefitinib resistant patients | |
| DE602006009539D1 (en) | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | |
| ATE476422T1 (en) | SUBSTITUTED 2-AMINOALKYLTHIO-BENZIMIDAZOLES AND THEIR USE FOR LOWERING BLOOD SUGAR | |
| BRPI0512422A (en) | compounds and compositions as protein kinase inhibitors | |
| Baker et al. | Differential effects of 5-HT2A and 5-HT2C receptor blockade on strategy-switching | |
| DE602006017574D1 (en) | USE AS PROTEIN KINASE INHIBITORS BENZIMIDAZOLE | |
| WO2005030151A3 (en) | Compounds and compositions as protein kinase inhibitors |